Goldman Sachs’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $171K | Buy |
280,223
+69,052
| +33% | +$42.2K | ﹤0.01% | 4768 |
|
|
2025
Q1 | $120K | Sell |
211,171
-94,837
| -31% | -$54.1K | ﹤0.01% | 4786 |
|
|
2024
Q4 | $438K | Sell |
306,008
-9,794
| -3% | -$14K | ﹤0.01% | 4365 |
|
|
2024
Q3 | $609K | Buy |
315,802
+95,819
| +44% | +$185K | ﹤0.01% | 4017 |
|
|
2024
Q2 | $682K | Buy |
219,983
+137,871
| +168% | +$427K | ﹤0.01% | 3794 |
|
|
2024
Q1 | $429K | Buy |
82,112
+7,627
| +10% | +$39.9K | ﹤0.01% | 4053 |
|
|
2023
Q4 | $241K | Sell |
74,485
-44,303
| -37% | -$144K | ﹤0.01% | 4261 |
|
|
2023
Q3 | $303K | Buy |
118,788
+43,517
| +58% | +$111K | ﹤0.01% | 4108 |
|
|
2023
Q2 | $442K | Buy |
75,271
+52,974
| +238% | +$311K | ﹤0.01% | 4041 |
|
|
2023
Q1 | $63.5K | Sell |
22,297
-18,649
| -46% | -$53.1K | ﹤0.01% | 4732 |
|
|
2022
Q4 | $82.3K | Buy |
40,946
+1,423
| +4% | +$2.86K | ﹤0.01% | 4714 |
|
|
2022
Q3 | $115K | Buy |
39,523
+20,275
| +105% | +$59K | ﹤0.01% | 4888 |
|
|
2022
Q2 | $108K | Sell |
19,248
-7,923
| -29% | -$44.5K | ﹤0.01% | 5091 |
|
|
2022
Q1 | $320K | Buy |
27,171
+12,870
| +90% | +$152K | ﹤0.01% | 4850 |
|
|
2021
Q4 | $271K | Buy |
+14,301
| New | +$271K | ﹤0.01% | 4828 |
|